Patient Decision Aid for Antidepressant Use in Pregnancy

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

November 30, 2017

Conditions
DepressionPregnancy
Interventions
BEHAVIORAL

Standard Resource Sheet

Women allocated to the control intervention will login to the study website and receive a printable PDF containing references to standard published information on antidepressant use in pregnancy. This ensures women have access to accurate information on the benefits and risks of antidepressant medication in pregnancy (even though they will not receive the PDA).

BEHAVIORAL

Patient Decision Aid

"The electronic Patient Decision Aid (PDA) is an interactive website with 3 main sections:~1. Evidence-based information on (a) depression in pregnancy, (b) each treatment option and procedure;~2. (a) Evidence-based information on the risks and benefits of both untreated depression and antidepressant treatment, (b) exercises to help women determine which risks and benefits are most important to them; and~3. A summary section that outlines the information reviewed and which benefits and risks they deemed most important.~At the end of the PDA, women allocated to this intervention will ALSO receive the standard resource sheet which is being used as the placebo comparator."

Trial Locations (1)

SE5 8AF

South London and Maudsley NHS Foundation Trust, London

All Listed Sponsors
collaborator

University of Toronto

OTHER

lead

King's College London

OTHER

NCT02492009 - Patient Decision Aid for Antidepressant Use in Pregnancy | Biotech Hunter | Biotech Hunter